Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden · Delayed Price · Currency is SEK 0.1145
-0.0015 (-1.29%)
Jul 24, 2026, 3:03 PM CET
Spago Nanomedical AB Market Cap
Spago Nanomedical AB has a market cap or net worth of 75.75 million as of July 24, 2026. Its market cap has decreased by -27.24% in one year.
Market Cap
75.75M
Enterprise Value
49.83M
Revenue
4.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
ChartMarket Cap Chart
Since January 16, 2013, Spago Nanomedical AB's market cap has increased from 46.44M to 75.75M, an increase of 63.11%. That is a compound annual growth rate of 3.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 75.75M | -1.72% |
| Dec 30, 2025 | 77.07M | 12.93% |
| Dec 30, 2024 | 68.25M | -4.38% |
| Dec 29, 2023 | 71.37M | 24.57% |
| Dec 30, 2022 | 57.29M | -71.02% |
| Dec 30, 2021 | 197.67M | -26.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 141.58M |
| NextCell Pharma AB | 128.92M |
| Alligator Bioscience AB | 123.49M |
| Alzinova AB | 108.16M |
| OncoZenge AB | 102.41M |
| Annexin Pharmaceuticals AB | 86.83M |
| AcouSort AB | 75.56M |
| Ascelia Pharma AB | 66.17M |